Key result
EF ≥50% predicts ~6-fold higher major event risk vs EF <50% after AF ablation in HF.
Why the study?
The safety and efficacy of AF ablation in patients with HF and preserved EF, particularly regarding post-procedural adverse events requiring hospitalization including anticoagulant-associated major bleeding, remain inconclusive.
Does the incidence of adverse events following catheter ablation for atrial fibrillation differ between heart failure patients with EF ≥ 50% versus EF < 50%?
Cohort (n=122)
No
Does the incidence of adverse events following catheter ablation for atrial fibrillation differ between heart failure patients with EF ≥ 50% versus EF < 50%?
In patients with heart failure undergoing atrial fibrillation ablation, those with preserved ejection fraction (EF ≥ 50%) have a significantly higher risk of post-procedural adverse events, primarily driven by major bleeding, compared to those with reduced ejection fraction.
Answers are grounded in this paper and cite their sources.
May warrant caution in HFpEF patients considered for AF ablation; hypothesis-generating and requires prospective validation.
Background: The safety and efficacy of atrial fibrillation (AF) ablation in individuals with heart failure (HF) with preserved ejection fraction (EF), particularly concerning the occurrence of post-procedural adverse events necessitating hospitalization, including anticoagulant-associated major bleeding, still lack conclusive determination. Methods: Data from patients with HF and AF who underwent catheter ablation for AF between 2019 and 2022 at our institution were retrospectively reviewed. All participants were divided into an EF < 50% group or an EF ≥ 50% group according to their baseline left ventricular EF. The composite incidence of the clinical events following catheter ablation was compared between the two groups: (1) all-cause death, (2) HF hospitalization, (3) stroke or systemic embolism, and (4) major bleeding. Results: A total of 122 patients (75 years old, 68 male) were included. Of them, 62 (50.8%) patients had an EF ≥ 50%. EF ≥ 50% was an independent predictor of the composite endpoint (adjusted odds ratio 6.07, 95% confidence interval 1.37–26.99, p = 0.018). The incidences of each adverse event were not significantly different between the two groups, except for a higher incidence of major bleeding in the EF ≥ 50% group (12.7% vs. 0%, p = 0.026). Conclusions: Among patients with HF coupled with AF, the incidence of adverse events following AF ablation proved notably elevated in patients with EF ≥ 50% in contrast to their counterparts with EF < 50%. This disparity primarily stems from a heightened occurrence of major bleeding within the EF ≥ 50% cohort. The strategy to reduce adverse events, especially in patients with EF ≥ 50%, remains the next concern.
No takes yet. Share an insight, caveat, or question.
Kataoka et al. (2024) conducted a cohort in Heart failure and atrial fibrillation (n=122). Baseline EF ≥ 50% vs. Baseline EF < 50% was evaluated on Composite of all-cause death, HF hospitalization, stroke or systemic embolism, and major bleeding (adjusted OR 6.07, 95% CI 1.37-26.99, p=0.018). Baseline EF ≥ 50% in patients with heart failure undergoing AF ablation predicted a higher risk of composite adverse events compared to EF < 50%.
Synapse has enriched 10 related papers. Consider them for comparative context: